- Grant of Options and PDMR Dealing
- Arecor to host company and KOL webinar today
- Positive headline results for AT278 clinical trial
- Final results for 2023
- Notice of Results
- Arecor and Medtronic Diabetes collaboration
- Publication of Full Year Financial Results delayed
- Notice of results
- BOARD CHANGE
- Arecor and TRx Biosciences research collaboration
More ▼
Key statistics
On Thursday, Arecor Therapeutics PLC (AREC:LSE) closed at 158.50, 27.51% above the 52 week low of 124.30 set on May 16, 2024.
52-week range
Open | 158.50 |
---|---|
High | 163.00 |
Low | 163.00 |
Bid | 145.00 |
Offer | 160.00 |
Previous close | 158.50 |
Average volume | 47.06k |
---|---|
Shares outstanding | 30.63m |
Free float | 14.86m |
P/E (TTM) | -- |
Market cap | 48.54m GBP |
EPS (TTM) | -0.28 GBP |
Data delayed at least 20 minutes, as of May 23 2024 17:05 BST.
More ▼